These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 7526784)
1. Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines. Rasmussen BA; Gluzman Y; Tally FP Antimicrob Agents Chemother; 1994 Jul; 38(7):1658-60. PubMed ID: 7526784 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines. Testa RT; Petersen PJ; Jacobus NV; Sum PE; Lee VJ; Tally FP Antimicrob Agents Chemother; 1993 Nov; 37(11):2270-7. PubMed ID: 8285606 [TBL] [Abstract][Full Text] [Related]
3. Mutations in the interdomain loop region of the tetA(A) tetracycline resistance gene increase efflux of minocycline and glycylcyclines. Tuckman M; Petersen PJ; Projan SJ Microb Drug Resist; 2000; 6(4):277-82. PubMed ID: 11272255 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Petersen PJ; Jacobus NV; Weiss WJ; Sum PE; Testa RT Antimicrob Agents Chemother; 1999 Apr; 43(4):738-44. PubMed ID: 10103174 [TBL] [Abstract][Full Text] [Related]
5. [Study of the mechanism of action of minocycline and of certain other tetracycline group compounds]. Beliavskaia IV; Kukhanova MK; Sazykin IUu ; Navashin SM Antibiotiki; 1976 Mar; 21(3):242-5. PubMed ID: 776077 [TBL] [Abstract][Full Text] [Related]
6. Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic. Grossman TH; Starosta AL; Fyfe C; O'Brien W; Rothstein DM; Mikolajka A; Wilson DN; Sutcliffe JA Antimicrob Agents Chemother; 2012 May; 56(5):2559-64. PubMed ID: 22354310 [TBL] [Abstract][Full Text] [Related]
7. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines. Kenny GE; Cartwright FD Antimicrob Agents Chemother; 1994 Nov; 38(11):2628-32. PubMed ID: 7872759 [TBL] [Abstract][Full Text] [Related]
8. New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors. Chopra I Drug Resist Updat; 2002; 5(3-4):119-25. PubMed ID: 12237079 [TBL] [Abstract][Full Text] [Related]
9. Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection. Bergeron J; Ammirati M; Danley D; James L; Norcia M; Retsema J; Strick CA; Su WG; Sutcliffe J; Wondrack L Antimicrob Agents Chemother; 1996 Sep; 40(9):2226-8. PubMed ID: 8878615 [TBL] [Abstract][Full Text] [Related]
10. Activity of glycylcyclines CL 329998 and CL 331002 against minocycline-resistant and other strains of methicillin-resistant Staphylococcus aureus. Hamilton-Miller JM; Shah S J Antimicrob Chemother; 1996 Jun; 37(6):1171-5. PubMed ID: 8836820 [TBL] [Abstract][Full Text] [Related]
11. Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline. Tuckman M; Petersen PJ; Howe AY; Orlowski M; Mullen S; Chan K; Bradford PA; Jones CH Antimicrob Agents Chemother; 2007 Sep; 51(9):3205-11. PubMed ID: 17620376 [TBL] [Abstract][Full Text] [Related]
12. Construction of an extended range whole-cell tetracycline biosensor by use of the tet(M) resistance gene. Bahl MI; Hansen LH; Sørensen SJ FEMS Microbiol Lett; 2005 Dec; 253(2):201-5. PubMed ID: 16239081 [TBL] [Abstract][Full Text] [Related]
14. Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome. Rasmussen B; Noller HF; Daubresse G; Oliva B; Misulovin Z; Rothstein DM; Ellestad GA; Gluzman Y; Tally FP; Chopra I Antimicrob Agents Chemother; 1991 Nov; 35(11):2306-11. PubMed ID: 1725100 [TBL] [Abstract][Full Text] [Related]
15. 16S rRNA mutations that confer tetracycline resistance in Helicobacter pylori decrease drug binding in Escherichia coli ribosomes. Nonaka L; Connell SR; Taylor DE J Bacteriol; 2005 Jun; 187(11):3708-12. PubMed ID: 15901694 [TBL] [Abstract][Full Text] [Related]
16. Negamycin induces translational stalling and miscoding by binding to the small subunit head domain of the Escherichia coli ribosome. Olivier NB; Altman RB; Noeske J; Basarab GS; Code E; Ferguson AD; Gao N; Huang J; Juette MF; Livchak S; Miller MD; Prince DB; Cate JH; Buurman ET; Blanchard SC Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16274-9. PubMed ID: 25368144 [TBL] [Abstract][Full Text] [Related]
17. The glycylcyclines: a comparative review with the tetracyclines. Zhanel GG; Homenuik K; Nichol K; Noreddin A; Vercaigne L; Embil J; Gin A; Karlowsky JA; Hoban DJ Drugs; 2004; 64(1):63-88. PubMed ID: 14723559 [TBL] [Abstract][Full Text] [Related]
18. Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria. Brown BA; Wallace RJ; Onyi G Antimicrob Agents Chemother; 1996 Apr; 40(4):874-8. PubMed ID: 8849243 [TBL] [Abstract][Full Text] [Related]
19. Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936). Hirata T; Saito A; Nishino K; Tamura N; Yamaguchi A Antimicrob Agents Chemother; 2004 Jun; 48(6):2179-84. PubMed ID: 15155219 [TBL] [Abstract][Full Text] [Related]
20. Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines. Sum PE; Lee VJ; Testa RT; Hlavka JJ; Ellestad GA; Bloom JD; Gluzman Y; Tally FP J Med Chem; 1994 Jan; 37(1):184-8. PubMed ID: 8289194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]